250 results on '"Rondan, Juan"'
Search Results
2. Frailty and P2Y12 Inhibitors: Does The Best Approach Need to Be Black or White?
3. Impacto de la COVID-19 en el tratamiento del infarto agudo de miocardio con elevación del segmento ST. La experiencia española
4. Intensified Antithrombotic Regimens After the Initial Period of Double Antiplatelet Therapy: Are We Following the Evidence?
5. Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry
6. Frailty and P2Y12 Inhibitors: Does The Best Approach Need to Be Black or White?
7. Long-term Follow-up After Percutaneous Treatment of the Unprotected Left Main Stenosis in High Risk Patients Not Suitable for Bypass Surgery
8. Results of Fractional Flow Reserve Measurement to Evaluate Nonculprit Coronary Artery Stenoses in Patients With Acute Coronary Syndrome
9. First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study
10. Prospective Application of Pre-Defined Intravascular Ultrasound Criteria for Assessment of Intermediate Left Main Coronary Artery Lesions: Results From the Multicenter LITRO Study
11. Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
12. Grado de conocimiento de stents coronarios, trombosis y doble antiagregación entre los odontólogos en España
13. Knowledge of Coronary Stents, Thrombosis, and Dual Antiplatelet Therapy Among Spanish Dentists
14. Low frequency of embolic protection devices in saphenous vein intervention: A matter of lack of conviction?
15. Cobalt-Chromium Stents in Long Lesions of Large Vessels: Clinical and Angiographic Results
16. Rotational Atherectomy with Drug-Eluting Stents: A Necessary Technique in the Current Era
17. Percutaneous Intervention in Bifurcations After the DKCRUSH-V Trial
18. Elevation of high-sensitivity cardiac troponin T and composite end points in randomized trials
19. Direct stenting should be attempted by default whenever possible
20. The dilemma of surgical or percutaneous approach in aortic stenosis: A reliable risk score is needed
21. Response to N P Curzenʼs: Is there evidence for prognostic benefit following PCI in stable patients? COURAGE and its implications: an interventionalistʼs view
22. Same-Day Discharge After Elective Percutaneous Intervention
23. SYNTAX score and left main stenting: Do we need clinical variables to predict outcomes?
24. Myocardial infarction in saphenous percutaneous intervention: Are we really doing our best?
25. Cardiac Catheterization Via the Right Radial Artery With a Judkins Left Catheter. A Prospective Study
26. Direct Stenting in Saphenous Vein Grafts. Immediate and Long-Term Results
27. Drug-Eluting Stents in Patients With Left Main Coronary Lesions Who Are Not Candidates for Surgical Revascularization
28. Implante de stent directo en puentes de safena. Resultados inmediatos y a largo plazo
29. Stent liberador de fármacos en lesiones de tronco coronario izquierdo en pacientes no candidatos a revascularización quirúrgica
30. TRANSFORM I: Knockout of Paclitaxel Over Sirolimus in Drug-Coated Balloons?
31. Access to side branches with a sharply angulated origin: usefulness of a specific wire for chronic occlusions
32. Acceso a ramas laterales con origen muy angulado: utilidad de una gu�a espec�fica de oclusi�n cr�nica
33. Duration of Dual-Antiplatelet Therapy After Left Main Stenting
34. Assessment of Platelet Reactivity After Transcatheter Aortic Valve Replacement
35. Strut Thickness and Patient´s Outcomes in Different End Points After Stent Implantation
36. Transfemoral Transcatheter Aortic Valve Replacement and On-Site Cardiac Surgery
37. The dilemma of identification of the culprit lesion in multivessel disease in patients with complex collateral circulation
38. De-Escalation of the P2Y12 Inhibitor After Acute Coronary Syndromes According to On-Treatment Platelet Reactivity
39. Lesion Complexity and Prolonged Antiplatelet Therapy
40. Chronic Kidney Disease and Antiplatelet Therapy
41. Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction
42. Cangrelor or Abciximab as First Choice in Cardiogenic Shock
43. Stent Choice in Very Large Left Main Lesions in 3 Patients
44. Definition of Myocardial Infarction Type 4a: Can We Define Its Diagnosis and Systematize Clinical Practice?
45. Duration of Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease
46. Letter by Lozano et al Regarding Article, “Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study”
47. Percutaneous Revascularization of Left Main Disease
48. Usefulness of the catheter extension in combination with the fractional flow reserve in coronary grafts
49. Outpatient percutaneous coronary intervention: An old technique necessary in the present and future
50. Pre-Hospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.